GL1X · GenesisL1 explorer

MolNFT v1 · #111130 · protein

Reversal agent for dabigatran

4YHI · Adabi-FAB2A heavy chain: “Reversal agent for dabigatran”. X-ray diffraction, 1 ligand (4CC), 12 pockets (best druggability 0.82). MolNFT v1 #111130 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4YHI
Type
protein
Length
882 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Adabi-FAB2A heavy chain; Adabi-FAB2A light chain
Ligands
4CC
Pockets
12 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, HAdabi-FAB2A heavy chainprotein2228% helix, 50% strand—
B, LAdabi-FAB2A light chainprotein2195% helix, 50% strand—

Ligands and binding sites

  • 4CC · N-[(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alanine · ligand · 2 copies · chains A, B, H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19330.820.8488empty
25120.730.8280empty
32220.730.8841empty
42510.690.8550empty
52750.610.8029empty

Interfaces

6 interfaces between chains.

  • A–B · 2054 Ų buried · 22 hydrogen bonds · protein-protein
  • H–L · 2042 Ų buried · 22 hydrogen bonds · protein-protein
  • A–H · 610 Ų buried · 6 hydrogen bonds · protein-protein
  • B–H · 557 Ų buried · 6 hydrogen bonds · protein-protein
  • A–L · 110 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 disulfide (disulfide).

Compared structures

  • 4YHI · Reversal Agent for Dabigatran · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.